Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Clin Nutr ; 93(5): 911-7, 2011 May.
Article in English | MEDLINE | ID: mdl-21367953

ABSTRACT

BACKGROUND: To our knowledge, changes in steroid metabolism in subjects with anorexia nervosa (AN) after weight gain have not been elucidated. OBJECTIVE: We characterized urinary steroid excretion and metabolism in AN patients and investigated the effects of refeeding. DESIGN: In an intervention study, we recruited 7 women with life-threatening weight loss upon admission and after a median [interquartile range (IQR)] of 95 d (88-125 d) of intensive refeeding; 15 age-matched women were recruited as control subjects. The major urinary metabolites were quantified in 24-h collections by capillary gas chromatography. A single examiner measured weights, heights, and skinfold thicknesses. RESULTS: The median (IQR) age of patients was 24 y (21-26 y), and the duration of AN was 4.0 y (3.3-8.0 y). Body mass index (BMI; in kg/m(2)) increased from 12.8 (12.7-13.1) to 18.6 (18.0-19.6) after refeeding (P < 0.0001). Steroid values [median pre-, post-refeeding (P value)] were as follows: androgen metabolites [472, 1017 µg/24 h (0.93)], cortisol metabolites [1960, 3912 µg/24 h (0.60)], and ratios of androsterone (5α)/etiocholanolone (5ß) [0.28, 0.63 (<0.001)], 5α-/5ß-tetrahydrocortisol [0.20, 0.48 (0.02)], tetrahydrocortisols/tetrahydrocortisone [0.87, 0.61 (0.09)], 20-hydroxy-/20-oxocortisol metabolites [0.29, 0.47 (0.01)], and 20α-/20ß-reduced cortisol metabolites [1.18, 1.89 (≥1.00)]. BMI change was positively correlated with 5α-/5ß-tetrahydrocortisol (r = 0.95, P < 0.001). Before refeeding, the following metabolites were lower in patients than in control subjects: androsterone, 5α-tetrahydrocortisol, α-cortolone and α-cortol, 5α-/5ß-tetrahydrocortisol, androsterone/etiocholanolone, and 20-hydroxy/20-oxocortisol (all P < 0.05). After refeeding, all steroid metabolites in patients were at concentrations that were comparable with those in control subjects. CONCLUSIONS: Significant changes in urine steroid-metabolite excretion occurred upon starvation, which were reversed upon refeeding. For cortisol, there were decreases in 5α-/5ß-tetrahydrocortisol and 20-hydroxy-/20-oxometabolites; for androgen, there was a decrease in androsterone/etiocholanolone.


Subject(s)
Androgens/metabolism , Androgens/urine , Anorexia Nervosa/diet therapy , Anorexia Nervosa/urine , Diet , Hydrocortisone/metabolism , Hydrocortisone/urine , Adult , Algorithms , Androsterone/urine , Anorexia Nervosa/metabolism , Body Mass Index , Etiocholanolone/urine , Female , Humans , Hydrocortisone/analogs & derivatives , Isomerism , Tetrahydrocortisol/urine , Young Adult
3.
J Child Psychol Psychiatry ; 48(6): 552-60, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17537071

ABSTRACT

BACKGROUND: There is growing evidence that family therapy is an effective treatment for adolescent anorexia nervosa. This study aimed to ascertain the long-term impact of two forms of outpatient family intervention previously evaluated in a randomised controlled trial (RCT). METHOD: A five-year follow-up was conducted on a cohort of 40 patients who had received either 'conjoint family therapy' (CFT) or 'separated family therapy' (SFT). All patients were traced and 38 agreed to be reassessed (29 interviewed in person, 3 completed telephone interviews, 6 completed questionnaires and/or agreed for parents/GP to be interviewed). RESULTS: Overall there was little to distinguish the two treatments at 5 years, with more than 75% of subjects having no eating disorder symptoms. There were no deaths in the cohort and only 8% of those who had achieved a healthy weight by the end of treatment reported any kind of relapse. Three patients developed bulimic symptoms but only one to a degree warranting a diagnosis of bulimia nervosa. The one difference between the treatments was in patients from families with raised levels of maternal criticism. This group of patients had done less well at the end of treatment if they had been offered conjoint family meetings. At follow-up this difference was still evident, as shown in the relative lack of weight gain since the end of outpatient treatment. CONCLUSIONS: This study confirms the efficacy of family therapy for adolescent anorexia nervosa, showing that those who respond well to outpatient family intervention generally stay well. The study provides further support for avoiding the use of conjoint family meetings at least early on in treatment when raised levels of parental criticism are evident.


Subject(s)
Anorexia Nervosa/therapy , Family Therapy/methods , Adolescent , Ambulatory Care , Anorexia Nervosa/diagnosis , Anorexia Nervosa/psychology , Body Weight , Bulimia Nervosa/diagnosis , Expressed Emotion , Female , Follow-Up Studies , Humans , Male , Maternal Behavior/psychology , Personality Assessment , Recurrence , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...